Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chandra Bhagat PharmaBOM:542934 65 PS Ratio is 0.34 as of Aug. 14, 2026, which is 28% below its 10-year median of 0.47. GuruFocus rates BOM:542934 with a GF Score™ of 65/100 and a GF Value™ of ₹70.14 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 118 Medical Distribution companies, Chandra Bhagat Pharma ranks better than 58.47% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Chandra Bhagat Pharma's share price is ₹52.50.
Chandra Bhagat Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹154.31. Hence, Chandra Bhagat Pharma's PS Ratio for today is 0.34.
The historical rank and industry rank for Chandra Bhagat Pharma's PS Ratio or its related term are showing as below:
BOM:542934'
s PS Ratio Range Over the Past 10 Years
Min: 0.18 Med: 0.47 Max: 1.49
Current: 0.32
During the past 10 years, Chandra Bhagat Pharma's highest PS Ratio was 1.49. The lowest was 0.18. And the median was 0.47.
BOM:542934's PS Ratio is ranked better than 58.47% of 118
companies
in the Medical Distribution industry
Industry Median: 0.405
vs BOM:542934: 0.32
During the past 12 months, the average Revenue per Share Growth Rate of Chandra Bhagat Pharma was 30.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -0.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 8.80% per year.
During the past 10 years, Chandra Bhagat Pharma's highest 3-Year average Revenue per Share Growth Rate was 46.30% per year. The lowest was -10.00% per year. And the median was -1.20% per year.
Chandra Bhagat Pharma (BOM:542934) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Chandra Bhagat Pharma's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandra Bhagat Pharma PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Chandra Bhagat Pharma's PS Ratio distribution charts can be found below:
* The bar in red indicates where Chandra Bhagat Pharma's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Chandra Bhagat Pharma's Share Price of today is ₹52.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chandra Bhagat Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹154.31.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Chandra Bhagat Pharma (BOM:542934) has a PS Ratio of 0.34 as of Aug. 14, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Chandra Bhagat Pharma and its competitors. This is 28% below median its historical median of 0.47. Over the past decade, Chandra Bhagat Pharma's PS Ratio has ranged from 0.18 to 1.49. According to the industry distribution chart, Chandra Bhagat Pharma ranks #49 out of 118 companies in the Medical Distribution industry, placing it in the top 41.5%.
Is Chandra Bhagat Pharma's PS Ratio too high?
Chandra Bhagat Pharma's current PS Ratio of 0.34 is 28% below median its 10-year median of 0.47. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 1.49. The Medical Distribution industry median PS Ratio is 0.41. Chandra Bhagat Pharma's value of 0.34 is 16% below this industry median. Based on the distribution chart, Chandra Bhagat Pharma ranks #49 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Chandra Bhagat Pharma has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chandra Bhagat Pharma's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Chandra Bhagat Pharma ranks #49 out of 118 companies for PS Ratio. This puts Chandra Bhagat Pharma in the upper half of its industry. The industry median PS Ratio is 0.41. Chandra Bhagat Pharma's value of 0.34 is 16% below this benchmark. Historically, Chandra Bhagat Pharma's own PS Ratio has ranged from 0.18 to 1.49 over the past decade. While the company's 10-year median is 0.47 vs. the industry median of 0.41, Chandra Bhagat Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.41, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chandra Bhagat Pharma's current PS Ratio of 0.34 is 16% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Chandra Bhagat Pharma and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chandra Bhagat Pharma's current PS Ratio is 0.34, which is 28% below median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandra Bhagat Pharma stock overvalued right now?
Based on GuruFocus' analysis, Chandra Bhagat Pharma (BOM:542934) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹70.14, compared to a current price of ₹52.50 — trading 25.1% below its estimated fair value. The current PS Ratio is 0.34, which is 28% below median its 10-year median of 0.47 and 16% below the Medical Distribution industry median of 0.41. Chandra Bhagat Pharma's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Chandra Bhagat Pharma (BOM:542934), the current PS Ratio is 0.34 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chandra Bhagat Pharma (BOM:542934) Overvalued in 2026?
Based on GuruFocus' analysis, Chandra Bhagat Pharma stock appears to be undervalued.
The current stock price of ₹52.50 is trading 25.1% below its estimated GF Value™ of ₹70.14.
GuruFocus considers Chandra Bhagat Pharma to be Modestly Undervalued.
Key valuation signals for BOM:542934:
PS Ratio: 0.34 (28% below median its 10-year median of 0.47)
GF Value™: ₹70.14 vs. price of ₹52.50 (25.1% below fair value)
Industry Position: 16% below the Medical Distribution median (#49 of 118)
No single metric tells the full story. See the BOM:542934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
65GF Score
Get the complete analysis for BOM:542934
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542934 has been successfully added to your 
